Continuous and Intermittent Glucose Monitoring in 2020

Ceriello A , Standl E , Catrinoiu D , et al. Issues of cardiovascular risk management in people with diabetes in the COVID-19 era. Diabetes Care, 2020; 43: 1427–1432.

Prabhu Navis J , Leelarathna L , Mubita W , et al. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England. Acta Diabetol 2020. Available at https://doi.org/10.1007/s00592-020-01614-5.

Maddaloni E , Coraggio L , Pieralice S , Carlone A , Pozzilli P , Buzzetti R . Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy. Diabetes Care, 2020; 43: e86–e87.

Dovc K , Osredkar SR , Schweiger DS , Battelino T , Bratina N . Nationwide digital/virtual diabetes care of children, adolescents and young adults with type 1 diabetes during a covid-19 pandemic in Slovenia. Zdr Vestn, 2020; 89: 626–633.

Phillip M , Bergenstal RM , Close KL , et al. The digital/virtual diabetes clinic: the future is now—recommendations from an international panel on diabetes digital technologies introduction. Diabetes Technol Ther, 2020; 23: 1–9.

Seiglie J , Platt J , Cromer SJ , et al. Diabetes as a risk factor for poor early outcomes in patients hospitalized with covid-19. Diabetes Care, 2020; 43: 2938–2944.

Battelino T , Bergenstal RM . Continuous glucose monitoring–derived data report-simply a better management tool. Diabetes Care, 2020; 43: 2327–2329.

Dovc K , Battelino T . Evolution of diabetes technology. Endocrinol Metab Clin North Am, 2020; 49: 1–18.

Dovc K , Battelino T . New technical approach to the diabetes therapy. Minerva Pediatr, 2020; 72: 263–277.

Dovc K , Battelino T . Time in range centered diabetes care. Clin Pediatr Endocrinol, 2021; 30: 1–10.

Rodriguez-Gutierrez R , McCoy RG . Measuring what matters in diabetes. JAMA, 2019; 321: 1865–1866.

Lind M , Polonsky W , Hirsch IB , et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections the gold randomized clinical trial. JAMA, 2017; 317: 379–387.

Battelino T , Danne T , Bergenstal RM , et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care, 2019; 42: 1593–1603.

Šuput Omladič J , Slana Ozimič A , Vovk A , et al. Acute hyperglycemia and spatial working memory in adolescents with type 1 diabetes. Diabetes Care, 2020; 43: 1941–1944.

Foland-Ross LC , Tong G , Mauras N , et al. Brain function differences in children with type 1 diabetes: a functional MRI study of working memory. Diabetes, 2020; 69: 1770–1778.

Van Loocke M , Battelino T , Tittel SR , et al. Lower HbA1c targets are associated with better metabolic control. Eur J Pediatr 2021 Jan 7. DOI: 10.1007/s00431-020-03891-2 [Epub ahead of print].

Redondo MJ , Libman I , Maahs DM , et al. The evolution of hemoglobin A 1c targets for youth with type 1 diabetes: rationale and supporting evidence. Diabetes Care, 2021; 44: 301–312.

Miller VA , Xiao R , Slick N , Feudtner C , Willi SM . Youth involvement in the decision to start CGM predicts subsequent CGM use. Diabetes Care, 2020; 43: 2355–2361.

Ahmadi SS , Westman K , Pivodic A , et al. The association between HbA1c and time in hypoglycemia during cgm and self-monitoring of blood glucose in people with type 1 diabetes and multiple daily insulin injections: a randomized clinical trial (GOLD-4). Diabetes Care, 2020; 43: 2017–2024.

Oliver N , Gimenez M , Calhoun P , et al. Continuous glucose monitoring in people with type 1 diabetes on multiple-dose injection therapy: the relationship between glycemic control and hypoglycemia. Diabetes Care, 2020; 43: 53–58.

Gómez AM , Henao DC , Imitola Madero A , et al. Defining high glycemic variability in type 1 diabetes: comparison of multiple indexes to identify patients at risk of hypoglycemia. Diabetes Technol Ther, 2019; 21: 430–439.

Monnier L , Wojtusciszyn A , Molinari N , Colette C , Renard E , Owens D . Respective contributions of glycemic variability and mean daily glucose as predictors of hypoglycemia in type 1 diabetes: are they equivalent?. Diabetes Care, 2020; 43: 821–827.

Wilmot EG , Choudhary P , Leelarathna L , Baxter M . Glycaemic variability: the under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes Metab 2019; 21: 2599–2608.

Battelino T , Dovč K . Glycemic variability: the danger of a physiologically stable metric. J Clin Endocrinol Metab, 2020; 105: e3815-e3817.

Beck RW , Bergenstal RM , Riddlesworth TD , et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care, 2019; 42: 400–405.

Little SA , Leelarathna L , Walkinshaw E , et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2×2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care, 2014; 37: 2114–2122.

Feig DS , Donovan LE , Corcoy R , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet, 2017; 390: 2347–2359.

Kar P . Technology and the NHS—a world of false promises?. BMJ, 2019; 367: l6135.

Charleer S , Mathieu C , Nobels F , et al. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab, 2018; 103: 1224–1232.

Charleer S , De Block C , Nobels F , et al. Sustained impact of real-time continuous glucose monitoring in adults with type 1 diabetes on insulin pump therapy: results after the 24-month rescue study. Diabetes Care, 2020; 43: 3016–3023.

Gomez-Peralta F , Dunn T , Landuyt K , Xu Y , Merino-Torres JF . Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ Open Diabetes Res Care, 2020; 8: e001052.

Boucher SE , Gray AR , Wiltshire EJ , et al. Effect of 6 months of flash glucose monitoring in youth with type 1 diabetes and high-risk glycemic control: a randomized controlled trial. Diabetes Care, 2020; 43: 2388–2395.

Evans M , Welsh Z , Ells S , Seibold A . The Impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies. Diabetes Ther, 2020; 11: 83–95.

Fortmann AL , Bagsic SRS , Talavera L , et al. Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting. Diabetes Care, 2020; 43: 2873–2877.

Barron E , Bakhai C , Kar P , et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol, 2020; 8: 813–822.

Ceriello A , Standl E , Catrinoiu D , et al. Issues of cardiovascular risk management in people with diabetes in the COVID-19 era. Diabetes Care, 2020; 43: 1427–1432.

Agarwal S , Mathew J , Davis GM , et al. Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care 2020: dc202219. DOI: 10.2337/dc20-2219 [Epub ahead of print].

Drole Torkar A , Plesnik E , Groselj U , Battelino T , Kotnik P . Carotid intima-media thickness in healthy children and adolescents: normative data and systematic literature review. Front Cardiovasc Med, 2020; 7: 597768.

Riddell MC , Gallen IW , Smart CE , et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol, 2017; 5: 377–390.

Burckhardt MA , Abraham MB , Mountain J , et al. Improvement in psychosocial outcomes in children with type 1 diabetes and their parents following subsidy for continuous glucose monitoring. Diabetes Technol Ther, 2019; 21: 538–545.

Addala A , Auzanneau M , Miller K , et al. A decade of disparities in diabetes technology use and HbA 1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care, 2021; 44: 133–140.

Maddaloni E , Coraggio L , Pieralice S , Carlone A , Pozzilli P , Buzzetti R . Effects of COVID-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy. Diabetes Care, 2020; 43: e86–e87.

Urakami T , Yoshida K , Kuwabara R , et al. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes. Endocr J, 2020; 67: 1055–1062.